Mark Muller

Dr. Muller has started several successful biotechnology companies and serves on multiple boards. As Founder and CEO of TopoGEN, Inc., he has grown the biotech company to a global presence.

TopoGEN manufacturers enzymes that can be used by researchers worldwide for cancer testing purposes. Dr. Muller got connected with Nanoly because he needed a technology that can remove the reliance of the cold chain for his products so that they can be more competitive worldwide both on cost (obviating the need for dry ice during shipping) and reliability (a product that can be held in customs without any spoilage).

​Dr. Muller previously was a Professor in Molecular Biology and Microbiology at UCF College of Medicine. In addition, he was selected as the Director of the Cancer Consortium of Central Florida where he studied the molecular biology of growth control in normal and cancer cells. Dr. Muller received his Ph.D. in Molecular Virology at the University of British Columbia.